Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aceragen Inc ACGN

Healthcare Biotechnology
Aceragen, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs. The Company’s pipeline includes ACG-701 to treat cystic fibrosis (CF) pulmonary exacerbations (PEx) and melioidosis, and... see more

Recent & Breaking News (NDAQ:ACGN)

Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology

GlobeNewswire August 24, 2016

Idera to Present at the 2016 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 12, 2016

Idera Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire August 2, 2016

Idera to Present at Two June Investor Healthcare Conferences

GlobeNewswire June 7, 2016

Idera Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire May 9, 2016

Idera to Release 2016 First Quarter Results on May 9, 2016

GlobeNewswire May 5, 2016

Idera Presents Preclinical Data Demonstrating Enhanced Systemic Anti-Tumor Activity from Combination Treatment with Intra-tumoral IMO-2125 and IDO-1 Inhibitor at AACR Annual Meeting 2016

GlobeNewswire April 19, 2016

Idera to Present at the 15th Annual Needham Healthcare Conference

GlobeNewswire April 11, 2016

Idera Pharmaceuticals Reports Fourth Quarter and Year End 2015 Financial Results and Provides Corporate Update

GlobeNewswire March 10, 2016

Idera to Present at Two March Investor Healthcare Conferences

GlobeNewswire March 3, 2016

Idera Pharmaceuticals Announces Appointment of Dr. Maxine Gowen to Its Board of Directors

GlobeNewswire January 6, 2016

Idera to Present at the 34th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 5, 2016

Idera Pharmaceuticals Announces Initiation of Phase 1/2 Clinical Trial of Intra-tumoral IMO-2125 in Combination With Ipilimumab in Patients With Metastatic Melanoma

GlobeNewswire December 14, 2015

Idera Pharmaceuticals Reports Positive Data From Ongoing Phase 1/2 Clinical Trial of IMO-8400 in Patients With Waldenstrom's Macroglobulinemia

GlobeNewswire December 5, 2015

Market Data on Movers and Shakers - Research on Medifast, Potbelly, Amarin and Idera Pharmaceuticals

Accesswire December 4, 2015

Idera Pharmaceuticals Announces Several Key Leadership Additions

GlobeNewswire November 30, 2015

Idera to Collaborate With GSK to Identify 3rd Generation Antisense Molecules for Treatment of Renal Disease

GlobeNewswire November 23, 2015

Equity Market Movement at a Glance - Research on Amarin, Idera Pharmaceuticals, AgroFresh Solutions and American Public Education

Accesswire November 19, 2015

Idera Announces Appointment of Joanna Horobin as Chief Medical Officer

GlobeNewswire November 18, 2015

Recent Technical Updates on Stocks from Diverse Sectors - Research on Medifast, Potbelly, AMARIN and Idera Pharmaceuticals

Accesswire November 9, 2015